Skip to content

Direct validation of renal123I-MIBG scintigraphy in humans

Direct validation of renal123I-MIBG scintigraphy in humans - DIVIDERE study

Status
Unknown
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON40382
Enrollment
12
Registered
2014-03-21
Start date
Unknown
Completion date
Unknown
Last updated
2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

sympathische zenuwstelsel en intrarenale zenuwen uptake and distribution of 123I-MIBG in the kidney (how much of the radioactive tracer 123I-MIBG is taken up by the kidney nerves)

Interventions

None listed

Sponsors

Academisch Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - age 18 to 85 years - able to give informed consent - scheduled for radical nephrectomy, nephron-sparing partial nephrectomy or nephroureterectomy (only scheduled on Tuesdays to Fridays)

Exclusion criteria

Exclusion criteria: - not willing to be informed about unexpected findings during the study - pregnancy - donor nephrectomy - nephrectomy scheduled on Mondays

Design outcomes

Primary

MeasureTime frame
to compare in vivo total kidney 123I-MIBG uptake (by counts per pixel) by 123I-MIBG scintigraphy to direct ex vivo 123I-MIBG uptake of the flushed kidney as directly assessed with phosphor imaging.

Secondary

MeasureTime frame
- to measure distribution of 123I-MIBG within the kidney - to compare the quantified 123I-MIBG and distribution of 123I-MIBG as assessed with phosphorus imaging to the histological distribution of sympathetic nerve endings by immunohistochemical neuron staining. - to compare 123I-MIBG uptake from in vivo renal 123I-MIBG scintigraphies, with 123I-MIBG uptake from ex vivo renal 123I-MIBG scintigraphies - to correlate the ex vivo renal 123I-MIBG scintigraphies with the direct ex vivo renal 123I-MIBG uptake as quantified by the phosphorus image plate.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)